KIMBERLY REYNOLDS: Open Payments
NPI 1568712834 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$833 in 44 payments from 15 companies in 2025. Trend: 2023 $513 · 2024 $582 · 2025 $833
Food & beverage: $833
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 20 | $359 |
| Globus Medical, Inc. | 5 | $114 |
| Merck Sharp & Dohme LLC | 4 | $85 |
| Alnylam Pharmaceuticals Inc. | 2 | $38 |
| Edwards Lifesciences Corporation | 1 | $34 |
| Novo Nordisk Inc | 2 | $33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $28 |
| Chiesi USA, Inc. | 1 | $26 |
| Kestra Medical Technology Services, Inc. | 1 | $24 |
| PFIZER INC. | 1 | $18 |
Products named: LEQVIO, Vyrsa V1, VERQUVO, ONPATTRO, SAPIEN 3 Ultra RESILIA, Wegovy, JARDIANCE, KENGREAL.
Industry payments across KY — which companies pay providers there.
